3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
4
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Interventions
Fluorouracil
3
Bevacizumab
3
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
trifluridine tipiracil drug combination
1
sintilimab
1
napabucasin
1
encorafenib
1
S-1 plus cisplatin
1
Paclitaxel
1
Oviposition
1
Levoleucovorin
1
Infliximab
1
Drug Therapy
1
Drainage
1
Cisplatin
1
Cetuximab
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Gastrointestinal Diseases
×
S-1 plus cisplatin
×
Clear all
NCT02322593
2021-12-20
SOLAR
Taiho Pharmaceutical Co., Ltd.
Phase 3
Completed
711 enrolled
16 charts